186 related articles for article (PubMed ID: 9348290)
1. Specific and redundant functions of retinoid X Receptor/Retinoic acid receptor heterodimers in differentiation, proliferation, and apoptosis of F9 embryonal carcinoma cells.
Chiba H; Clifford J; Metzger D; Chambon P
J Cell Biol; 1997 Nov; 139(3):735-47. PubMed ID: 9348290
[TBL] [Abstract][Full Text] [Related]
2. Distinct retinoid X receptor-retinoic acid receptor heterodimers are differentially involved in the control of expression of retinoid target genes in F9 embryonal carcinoma cells.
Chiba H; Clifford J; Metzger D; Chambon P
Mol Cell Biol; 1997 Jun; 17(6):3013-20. PubMed ID: 9154799
[TBL] [Abstract][Full Text] [Related]
3. RXRalpha-null F9 embryonal carcinoma cells are resistant to the differentiation, anti-proliferative and apoptotic effects of retinoids.
Clifford J; Chiba H; Sobieszczuk D; Metzger D; Chambon P
EMBO J; 1996 Aug; 15(16):4142-55. PubMed ID: 8861943
[TBL] [Abstract][Full Text] [Related]
4. F9 embryocarcinoma cells: a cell autonomous model to study the functional selectivity of RARs and RXRs in retinoid signaling.
Rochette-Egly C; Chambon P
Histol Histopathol; 2001 Jul; 16(3):909-22. PubMed ID: 11510982
[TBL] [Abstract][Full Text] [Related]
5. Synergistic activation of retinoic acid (RA)-responsive genes and induction of embryonal carcinoma cell differentiation by an RA receptor alpha (RAR alpha)-, RAR beta-, or RAR gamma-selective ligand in combination with a retinoid X receptor-specific ligand.
Roy B; Taneja R; Chambon P
Mol Cell Biol; 1995 Dec; 15(12):6481-7. PubMed ID: 8524212
[TBL] [Abstract][Full Text] [Related]
6. Effects of novel retinoid X receptor-selective ligands on myeloid leukemia differentiation and proliferation in vitro.
Kizaki M; Dawson MI; Heyman R; Elster E; Morosetti R; Pakkala S; Chen DL; Ueno H; Chao W; Morikawa M; Ikeda Y; Heber D; Pfahl M; Koeffler HP
Blood; 1996 Mar; 87(5):1977-84. PubMed ID: 8634447
[TBL] [Abstract][Full Text] [Related]
7. Effects of novel RAR- and RXR-selective retinoids on myeloid leukemic proliferation and differentiation in vitro.
Shiohara M; Dawson MI; Hobbs PD; Sawai N; Higuchi T; Koike K; Komiyama A; Koeffler HP
Blood; 1999 Mar; 93(6):2057-66. PubMed ID: 10068679
[TBL] [Abstract][Full Text] [Related]
8. Cell-type and promoter-context dependent retinoic acid receptor (RAR) redundancies for RAR beta 2 and Hoxa-1 activation in F9 and P19 cells can be artefactually generated by gene knockouts.
Taneja R; Roy B; Plassat JL; Zusi CF; Ostrowski J; Reczek PR; Chambon P
Proc Natl Acad Sci U S A; 1996 Jun; 93(12):6197-202. PubMed ID: 8650243
[TBL] [Abstract][Full Text] [Related]
9. Regulation of retinoid-induced differentiation in embryonal carcinoma PCC4.aza1R cells: effects of retinoid-receptor selective ligands.
Mills KJ; Vollberg TM; Nervi C; Grippo JF; Dawson MI; Jetten AM
Cell Growth Differ; 1996 Mar; 7(3):327-37. PubMed ID: 8838863
[TBL] [Abstract][Full Text] [Related]
10. Retinoid X receptor-specific retinoids inhibit the ability of retinoic acid receptor-specific retinoids to increase the level of insulin-like growth factor binding protein-3 in human ectocervical epithelial cells.
Hembree JR; Agarwal C; Beard RL; Chandraratna RA; Eckert R
Cancer Res; 1996 Apr; 56(8):1794-9. PubMed ID: 8620495
[TBL] [Abstract][Full Text] [Related]
11. Retinoic acid receptors alpha and gamma mediate the induction of "tissue" transglutaminase activity and apoptosis in human neuroblastoma cells.
Melino G; Draoui M; Bellincampi L; Bernassola F; Bernardini S; Piacentini M; Reichert U; Cohen P
Exp Cell Res; 1997 Aug; 235(1):55-61. PubMed ID: 9281352
[TBL] [Abstract][Full Text] [Related]
12. Gene expression profiling elucidates a specific role for RARgamma in the retinoic acid-induced differentiation of F9 teratocarcinoma stem cells.
Su D; Gudas LJ
Biochem Pharmacol; 2008 Mar; 75(5):1129-60. PubMed ID: 18164278
[TBL] [Abstract][Full Text] [Related]
13. Keratinocyte-specific retinoid regulation of human cellular retinoic acid binding protein-II (hCRABPII) gene promoter requires an evolutionarily conserved DR1 retinoic acid-responsive element.
Di W; Li XY; Datta S; Aström A; Fisher GJ; Chambon P; Voorhees JJ; Xiao JH
J Invest Dermatol; 1998 Dec; 111(6):1109-15. PubMed ID: 9856825
[TBL] [Abstract][Full Text] [Related]
14. 4HPR triggers apoptosis but not differentiation in retinoid sensitive and resistant human embryonal carcinoma cells through an RARgamma independent pathway.
Kitareewan S; Spinella MJ; Allopenna J; Reczek PR; Dmitrovsky E
Oncogene; 1999 Oct; 18(42):5747-55. PubMed ID: 10523855
[TBL] [Abstract][Full Text] [Related]
15. Identification of receptor-selective retinoids that are potent inhibitors of the growth of human head and neck squamous cell carcinoma cells.
Sun SY; Yue P; Mao L; Dawson MI; Shroot B; Lamph WW; Heyman RA; Chandraratna RA; Shudo K; Hong WK; Lotan R
Clin Cancer Res; 2000 Apr; 6(4):1563-73. PubMed ID: 10778990
[TBL] [Abstract][Full Text] [Related]
16. Activation of three distinct RXR/RAR heterodimers induces growth arrest and differentiation of neuroblastoma cells.
Giannini G; Dawson MI; Zhang X; Thiele CJ
J Biol Chem; 1997 Oct; 272(42):26693-701. PubMed ID: 9334253
[TBL] [Abstract][Full Text] [Related]
17. Physiological and retinoid-induced proliferations of epidermis basal keratinocytes are differently controlled.
Chapellier B; Mark M; Messaddeq N; Calléja C; Warot X; Brocard J; Gérard C; Li M; Metzger D; Ghyselinck NB; Chambon P
EMBO J; 2002 Jul; 21(13):3402-13. PubMed ID: 12093741
[TBL] [Abstract][Full Text] [Related]
18. Specific activation of retinoic acid receptors (RARs) and retinoid X receptors reveals a unique role for RARgamma in induction of differentiation and apoptosis of S91 melanoma cells.
Spanjaard RA; Ikeda M; Lee PJ; Charpentier B; Chin WW; Eberlein TJ
J Biol Chem; 1997 Jul; 272(30):18990-9. PubMed ID: 9228081
[TBL] [Abstract][Full Text] [Related]
19. Retinoid X receptor alpha and retinoic acid receptor gamma mediate expression of genes encoding tight-junction proteins and barrier function in F9 cells during visceral endodermal differentiation.
Kubota H; Chiba H; Takakuwa Y; Osanai M; Tobioka H; Kohama G; Mori M; Sawada N
Exp Cell Res; 2001 Feb; 263(1):163-72. PubMed ID: 11161715
[TBL] [Abstract][Full Text] [Related]
20. The expression and activity of D-type cyclins in F9 embryonal carcinoma cells: modulation of growth by RXR-selective retinoids.
Li Y; Glozak MA; Smith SM; Rogers MB
Exp Cell Res; 1999 Dec; 253(2):372-84. PubMed ID: 10585260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
